Cerebral Palsy Clinical Trial
— PRINTOfficial title:
The Feasibility and Acceptability of 3D Printed Orthotics in Children and Adolescents
NCT number | NCT03770949 |
Other study ID # | 233504 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 31, 2018 |
Est. completion date | September 1, 2019 |
Verified date | November 2018 |
Source | Barts & The London NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
PRINT is a prospective mixed methods study exploring the feasibility and acceptability of providing 3-D printed orthotics specifically an ankle foot orthosis (AFO) to children and adolescents with cerebral palsy.
Status | Completed |
Enrollment | 17 |
Est. completion date | September 1, 2019 |
Est. primary completion date | September 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Years to 16 Years |
Eligibility | Inclusion Criteria: - Children/adolescents 3-16 years of age with hemiplegia resulting from cerebral palsy who are categorized as either level 1 or level 2 as per the Gross Motor Function Classification for cerebral palsy assessed through a chart review (Children at this level will be able to participate in and complete a walking test) - Children/adolescents with an identified clinical need for an AFO whose ankle can be held in a corrected position with minimal manual support - Children/adolescents who are prescribed an AFO for maintenance only assessed through chart review (maintaining joint position) - Children/adolescents who have previously been prescribed a standard thermoplastic orthotic assessed through chart review Exclusion Criteria: - Children/adolescents who require significant amount of manual correction to position their foot - Children/adolescents with dystonia, spastic diplegia or total body involvement - Children/adolescents who require bilateral orthotics - Children/adolescents who require corrective therapy such as serial casting to stretch and reposition the foot and ankle - Children/adolescents who are participating in another research study that may impact on ankle range of motion or calf muscle length or increase participant burden on parents/participants. - Children/adolescents weighing more than 62kg as assessed through a chart review - Children/adolescents that have photo-sensitivity (e.g. epilepsy) assessed through chart review |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Barts Health NHS Trust, Royal London Hospital | London |
Lead Sponsor | Collaborator |
---|---|
Barts & The London NHS Trust | Andiamo, Innovate UK |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Interviews | Semi-structured interviews with participants and their parents/guardians will be completed to explore the experience of being fitted for and receiving a 3-D printed AFO. Interviews will be analyzed using framework analysis, findings will be reported as common themes identified throughout the interviews. Interviews will last approximately 20-30 minutes. | Interviews will be conducted at visit 4 (9 weeks). | |
Secondary | Pediatric Quality of Life Inventory TM: PedsQL | Self-reported assessment of quality of life will be assessed using the PedsQL. The PedsQL encompasses functional tasks, feelings/emotions, how someone gets on with others, school activities, and participation. The PedsQL has both child report and parent proxy report; there are different questionnaires for different age groups ranging from toddlers to adolescents. Questions are scored on a 5 point Likert scale from 0 to 4; higher scores indicate better health related quality of life.The PedsQL will take approximately 5-10 minutes to complete. | PedsQL assessed at visit 1 (baseline), 3 (6 weeks), and 4 (9 weeks). | |
Secondary | Timed Up and Go Test (TUG) | The TUG is a functional assessment evaluating sit-stand, ambulation, and turning. The participant starts from a seated position, on 'go' the participant rises from the chair, walks 3 meters turns, walks back to the chair and sits. The test is timed from 'go' to when the participant is back seated in the chair to the nearest centisecond for example 13.46 seconds. This assessment can be done with and with out assistive devices such as walkers or crutches. Faster times are associated with better functional mobility. Three trials will be completed. The TUG will take around 10 minutes to complete. | The TUG will be assessed at visit 1 (baseline), 3 (6 weeks), and 4 (9 weeks). | |
Secondary | Range of Motion Assessment | Ankle range of motion (ROM) will be assessed using a goniometer, the gold standard in range of motion assessment. The ankle motions assessed are dorsiflexion and plantar flexion to the nearest degree. Three measurement trials will be completed. Ankle range of motion will take approximately 5 minutes to complete. | ROM assessment will be completed at visit 1 (baseline), 3 (6 weeks), and 4 (9 weeks). | |
Secondary | Resource use/clinical data: previous ankle foot orthoses | Participants and their parents/guardians will complete a questionnaire regarding resource use and clinical data such as previous AFO's recording the number of previous AFO's the participant has had. | The resource use and clinical data will be assessed at visit 4 (9 weeks). | |
Secondary | Resource use/clinical data: Gross Motor Function Classification System | Participants and their parents/guardians will complete a questionnaire of resource use and clinical data including reporting the participants Gross Motor Function Classification System (GMFCS) which assesses the individuals motor function. The GMFCS level will be the level the individuals scored at their most recent assessment, obtained from participant/guardian report or chart review. GMFCS levels range from I-V; lower levels are associated with higher functioning. | The resource use and clinical data will be assessed at visit 4 (9 weeks) and during screening of patients.. | |
Secondary | Resource use/clinical data: number of fitting appointments | Participants and their parents/guardians will complete a questionnaire of resource use and clinical data including the number of fitting appointments attended to achieve proper AFO fit. This will be done by recording the number of fitting appointments for both the 3-D printed AFO and previous standard AFO's the participant has had. | The resource use and clinical data will be assessed at visit 4 (9 weeks). | |
Secondary | Resource use/clinical data: compliance wearing the AFO | Participants and their parents/guardians will complete a questionnaire regarding resource use and clinical data with questions around compliance with wearing the AFO measured as "yes" compliant with the amount of time prescribed to wear AFO; or "no" not complaint with the amount of team prescribed to wear the AFO and reasons why not complaint (open ended question participant generates their own response). | The resource use and clinical data will be assessed at visit 4 (9 weeks). | |
Secondary | Resource use/clinical data: skin integrity | Participants and their parents/guardians will complete a questionnaire regarding resource use and clinical data with questions around skin integrity (redness, rubbing, skin breakdown) whilst wearing the 3-D printed AFO. | The resource use and clinical data will be assessed at visit 4 (9 weeks). | |
Secondary | 3-D scanning of the lower limb | The foot and ankle will be scanned using an Artec Eva scanner on a Microsoft Surface 4 tablet with Windows 10. The 3-D scan is what is used to develop and generate the 3-D printed AFO.
During scanning the tablet camera is used to take a 3-D scan/image of the lower leg, ankle, and foot. The participant does not have to do anything during the 3-D scan. The participant's foot will be placed in the optimal position for the scan and the tablet camera will be moved around the participants' leg and foot to obtain the 3-D image. The 3-D scan is painless and takes around fifteen minutes. There are no specific measurements associated with the scanning. |
Visit 1 (baseline assessment) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05317234 -
Genetic Predisposition in Cerebral Palsy
|
N/A | |
Recruiting |
NCT05576948 -
Natural History of Cerebral Palsy Prospective Study
|
||
Completed |
NCT04119063 -
Evaluating Wearable Robotic Assistance on Gait
|
Early Phase 1 | |
Completed |
NCT03264339 -
The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy
|
N/A | |
Completed |
NCT05551364 -
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT03902886 -
Independent Walking Onset of Children With Cerebral Palsy
|
||
Recruiting |
NCT05571033 -
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT04081675 -
Compliance in Children With Cerebral Palsy Supplied With AFOs
|
||
Completed |
NCT02167022 -
Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy
|
N/A | |
Completed |
NCT04012125 -
The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy
|
N/A | |
Enrolling by invitation |
NCT05619211 -
Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
|
Phase 1 | |
Completed |
NCT04489498 -
Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
|
||
Completed |
NCT03677193 -
Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy
|
N/A | |
Recruiting |
NCT06450158 -
Robot-assisted Training in Children With CP
|
N/A | |
Completed |
NCT04093180 -
Intensive Neurorehabilitation for Cerebral Palsy
|
N/A | |
Completed |
NCT02909127 -
The Pediatric Eating Assessment Tool
|
||
Not yet recruiting |
NCT06377982 -
Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy
|
Phase 1 | |
Not yet recruiting |
NCT06007885 -
Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.
|
N/A | |
Not yet recruiting |
NCT03183427 -
Corpus Callosum Size in Patients With Pineal Cyst
|
N/A | |
Active, not recruiting |
NCT03078621 -
Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy
|
Phase 1/Phase 2 |